These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1172408)

  • 1. Effects of 5-bromodeoxyuridine and 5-iododeoxyuridine on a latent herpes simplex virus infection.
    Varani J; Kelleher JJ
    Antimicrob Agents Chemother; 1975 Jul; 8(1):18-21. PubMed ID: 1172408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 5'-amino-5-iodo-2',5'-dideoxyuridine and 2-deoxy-D-glucose on latent ganglionic herpes simplex virus infection.
    Pavan-Langston D; Park NH; De Clercq E
    Antiviral Res; 1984 Apr; 4(1-2):53-61. PubMed ID: 6331305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of idoxuridine analogs into corneal herpes simplex virus.
    Hanna C
    Ann Ophthalmol; 1972 Nov; 4(11):991-6. PubMed ID: 4265776
    [No Abstract]   [Full Text] [Related]  

  • 4. (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.
    Maudgal PC; De Clercq E; Descamps J; Missotten L; De Somer P; Busson R; Vanderhaeghe H; Verhelst G; Walker RT; Jones AS
    Antimicrob Agents Chemother; 1980 Jan; 17(1):8-12. PubMed ID: 7352751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of 5-iodo-2-deoxyuridine (Idoxuridine) in cutaneous herpes simplex.
    Key JM
    Calif Med; 1965 Oct; 103(4):247-8. PubMed ID: 5318352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections.
    Maudgal PC; De Clercq E; Missotten L
    Antiviral Res; 1984 Oct; 4(5):281-91. PubMed ID: 6335020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical treatment of cutaneous herpes simplex virus infection in hairless mice with (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    de Clercq E
    Antimicrob Agents Chemother; 1984 Aug; 26(2):155-9. PubMed ID: 6486759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine against different herpes simplex virus strains in cell culture and against experimental herpes encephalitis in mice.
    Reefschläger J; Wutzler P; Thiel KD; Bärwolff D; Langen P; Sprössig M; Rosenthal HA
    Antiviral Res; 1982 Oct; 2(5):255-65. PubMed ID: 6295273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of BVDU ((E)-5-(2-bromovinyl)-2'-deoxyuridine) in the treatment of experimental herpes simplex keratitis in rabbits.
    Maudgal PC; De Clercq E; Descamps J; Missotten L
    Bull Soc Belge Ophtalmol; 1979; 186():109-18. PubMed ID: 554711
    [No Abstract]   [Full Text] [Related]  

  • 10. [UV inactivation of herpes simplex virus from cell cultures treated with 5-bromodeoxyuridine and 5-iododeoxyuridine].
    Schneweis KE
    Arch Gesamte Virusforsch; 1969; 28(2):203-11. PubMed ID: 4313033
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiviral activity of 5-iodo-2'-deoxyuridine and related drugs in human keratinocytes infected in vitro with herpes simplex virus type 1.
    Reuveni H; Bull CO; Landry ML; Milstone LM; Schwartz PM
    Skin Pharmacol; 1991; 4(4):291-7. PubMed ID: 1665069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine in the treatment of experimental herpes simplex virus encephalitis in mice.
    Park NH; Pavan-Langston D; de Clercq E
    Antiviral Res; 1983 Mar; 3(1):7-15. PubMed ID: 6870230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of 5-iodo-2'-deoxyuridine (IDU) on ultrastructural localization of viral antigens in cultured cells infected with herpes simplex virus (HSV)].
    Yoshida H
    Nippon Ganka Gakkai Zasshi; 1982; 86(8):850-66. PubMed ID: 6758556
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice.
    de Clercq E; Zhang ZX; Sim IS
    Antimicrob Agents Chemother; 1982 Sep; 22(3):421-5. PubMed ID: 7137983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.
    Lawrence TS; Davis MA; Maybaum J; Mukhopadhyay SK; Stetson PL; Normolle DP; McKeever PE; Ensminger WD
    Cancer Res; 1992 Jul; 52(13):3698-704. PubMed ID: 1617642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of herpetic infections].
    Barinskiĭ IF; L'vov ND; Samoĭlovich EO
    Vopr Virusol; 1986; 31(1):6-18. PubMed ID: 3515765
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of high dose 5-iodo-2'-deoxyuridine in the therapy of herpes simplex virus encephalitis. Evidence of unacceptable toxicity.
    ;
    N Engl J Med; 1975 Mar; 292(12):599-603. PubMed ID: 1089874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2.
    Ayisi NK; Gupta VS; Meldrum JB; Taneja AK; Babiuk LA
    Antimicrob Agents Chemother; 1980 Apr; 17(4):558-66. PubMed ID: 6249191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of genital herpes simplex virus type 2 infections of female hamsters.
    Renis HE
    Antimicrob Agents Chemother; 1977 Apr; 11(4):701-7. PubMed ID: 856023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Herpes encephalitis treated with 5-iodo-2-deoxyuridine].
    Goldman B; Nahor A; Braham J; Padeh B
    Harefuah; 1971 Jan; 80(2):58-60. PubMed ID: 5098845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.